United Therapeutics | Ativo Circulante



Current Assets Alterar Data
Amarin USD 650.22M 51.62M 2024-09
Ardelyx USD 356.45M 72.35M 2024-12
Baxter International USD 8.85B 11M 2024-12
Bayer EUR 34.44B 1.31B 2024-12
Biogen USD 7.46B 626.3M 2024-12
BioMarin Pharmaceutical USD 3.23B 175.84M 2024-12
Gilead Sciences USD 19.17B 4.39B 2024-12
GlaxoSmithKline GBP 18.08B 1.09B 2025-03
Halozyme Therapeutics USD 1.09B 41.64M 2024-12
Insmed USD 1.62B 28.18M 2024-12
Ionis Pharmaceuticals USD 2.42B 201.36M 2025-03
J&J USD 71.55B 15.66B 2025-03
Moderna USD 6.77B 1.33B 2025-03
Pfizer USD 50.36B 7.14B 2024-12
PTC Therapeutics USD 1.37B 83.98M 2024-12
Regeneron Pharmaceuticals USD 17.57B 9.64B 2025-03
Sarepta Therapeutics USD 3.07B 388.09M 2024-12
Teva Pharmaceutical Industries USD 12.55B 238M 2024-12
United Therapeutics USD 3.94B 65.9M 2025-03
Vertex Pharmaceuticals USD 9.6B 207.7M 2024-12



United Therapeutics Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.